The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
01 2023
Historique:
revised: 09 11 2022
received: 20 07 2022
accepted: 11 12 2022
pubmed: 15 12 2022
medline: 11 1 2023
entrez: 14 12 2022
Statut: ppublish

Résumé

The severity of COVID-19 is associated with individual genetic host factors. Among these, genetic polymorphisms affecting natural killer (NK) cell responses, as variations in the HLA-E- (HLA-E*0101/0103), FcγRIIIa- (FcγRIIIa-158-F/V), and NKG2C- (KLRC2

Identifiants

pubmed: 36515427
doi: 10.1002/jmv.28404
pmc: PMC9878105
doi:

Substances chimiques

KLRC2 protein, human 0
NK Cell Lectin-Like Receptor Subfamily C 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28404

Informations de copyright

© 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

Références

Lancet Respir Med. 2022 Mar;10(3):223-224
pubmed: 34863335
Sci Immunol. 2020 Aug 21;5(50):
pubmed: 32826343
J Immunol. 2012 Apr 1;188(7):3315-22
pubmed: 22345646
Front Public Health. 2022 Feb 11;10:833967
pubmed: 35223745
Clin Transl Immunology. 2022 Jan 11;11(1):e1359
pubmed: 35035954
JCI Insight. 2021 Aug 9;6(15):
pubmed: 34185704
J Biol Chem. 2003 Feb 14;278(7):5082-90
pubmed: 12411439
Blood. 1997 Aug 1;90(3):1109-14
pubmed: 9242542
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Front Immunol. 2022 Mar 24;13:829228
pubmed: 35401541
Genet Med. 2021 May;23(5):963-967
pubmed: 33500568
Eur Respir J. 2020 Sep 24;56(3):
pubmed: 32747391
Front Public Health. 2021 Aug 06;9:584182
pubmed: 34422736
Virus Res. 2020 Nov;289:198171
pubmed: 32979474
Cell Syst. 2022 Aug 17;13(8):598-614.e6
pubmed: 35690068
Immunology. 2009 Apr;126(4):458-65
pubmed: 19278419
J Med Virol. 2023 Jan;95(1):e28404
pubmed: 36515427
Hum Genomics. 2021 Aug 25;15(1):57
pubmed: 34429158
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Cell Mol Immunol. 2021 Mar;18(3):604-612
pubmed: 33060840
Genet Med. 2022 Jul;24(7):1449-1458
pubmed: 35488894

Auteurs

Hannes Vietzen (H)

Center for Virology, Medical University of Vienna, Vienna, Austria.

Philippe L Furlano (PL)

Center for Virology, Medical University of Vienna, Vienna, Austria.

Marianna Traugott (M)

Department of Medicine IV, Clinic Favoriten, Vienna, Austria.

David Totschnig (D)

Department of Medicine IV, Clinic Favoriten, Vienna, Austria.

Wolfgang Hoepler (W)

Department of Medicine IV, Clinic Favoriten, Vienna, Austria.

Robert Strassl (R)

Division of Clinical Virology, Medical University of Vienna, Vienna, Austria.

Alexander Zoufaly (A)

Department of Medicine IV, Clinic Favoriten, Vienna, Austria.
Faculty of Medicine, Sigmund Freud University, Vienna, Austria.

Elisabeth Puchhammer-Stöckl (E)

Center for Virology, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH